These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11477672)

  • 1. Extent and time course of morphological changes of bone marrow induced by granulocyte-colony stimulating factor as assessed by magnetic resonance imaging of healthy blood stem cell donors.
    Altehoefer C; Bertz H; Ghanem NA; Langer M
    J Magn Reson Imaging; 2001 Aug; 14(2):141-6. PubMed ID: 11477672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Randomized clinical study for two types of recombinant human granulocyte colony-stimulating factor mobilizing peripheral blood and bone marrow stem cells in patients receiving allogeneic hematopoietic stem cell transplantation].
    Zhang XH; Huang XJ; Liu DH; Liu KY; Han W; Chen H; Wang FR; Chen YH; Wang JZ; Zhao T; Wang Y; Xu LP
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2116-9. PubMed ID: 20058615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of factors for poor mobilization after administration of recombinant human granulocyte stimulating factor (rHuG-CSF) in healthy donors].
    Aoyama Y; Nakamae H; Yamamura R; Makita K; Shima E; Hasegawa T; Sakamoto C; Kho G; Ohta K; Yamane T; Takubo T; Hino M
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):829-36. PubMed ID: 12852351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor.
    Falanga A; Marchetti M; Evangelista V; Manarini S; Oldani E; Giovanelli S; Galbusera M; Cerletti C; Barbui T
    Blood; 1999 Apr; 93(8):2506-14. PubMed ID: 10194429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of in vivo lenograstim (rHuG-CSF) for stem cell collection demonstrates improved neutrophil recovery after autologous bone marrow transplantation.
    Stoppa AM; Blaise D; Viens P; Baume D; Mannoni P; Novakovitch G; David FA; Yver A; Maraninchi D
    Bone Marrow Transplant; 1994 May; 13(5):541-7. PubMed ID: 7519936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Administration of leukemic granulocyte colony-stimulating factor to donors: the changes in donor bone marrow cell composition and the transplantation outcome].
    Ji S; Chen H; Wang H; Yan H; Pan S
    Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):834-7. PubMed ID: 16206675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of glycosylated recombinant human granulocyte colony-stimulating factor after HLA-identical sibling bone marrow transplantation.
    Lickliter JD; Roberts AW; Grigg AP
    Aust N Z J Med; 1994 Oct; 24(5):541-6. PubMed ID: 7531433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression.
    Rutella S; Rumi C; Pierelli L; Morosetti R; Sica S; Bonanno G; Scambia G; Leone G
    Exp Hematol; 2000 Jun; 28(6):612-25. PubMed ID: 10880747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors.
    Stroncek DF; Clay ME; Smith J; Ilstrup S; Oldham F; McCullough J
    Transfusion; 1996 Jul; 36(7):596-600. PubMed ID: 8701454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of recombinant human granulocyte-colony-stimulating factor does not induce long-lasting detectable epigenetic alterations in healthy donors.
    Leitner GC; Faschingbauer M; Wenda S; Weigel G; Fischer G
    Transfusion; 2014 Dec; 54(12):3121-6. PubMed ID: 24861153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of bone marrow graft collection on composition of peripheral blood stem cell grafts from healthy donors after recombinant human granulocyte colony-stimulating factor application in vivo for mobilization].
    Chang YJ; Zhao XY; Huo MR; Luo XH; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):610-3. PubMed ID: 18549639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor.
    Cella G; Marchetti M; Vignoli A; Randi ML; Saggiorato G; Pasetto L; Pagnan A; Barbui T; Falanga A
    Leukemia; 2006 Aug; 20(8):1430-4. PubMed ID: 16775616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.
    Stroncek DF; Clay ME; Petzoldt ML; Smith J; Jaszcz W; Oldham FB; McCullough J
    Transfusion; 1996 Jul; 36(7):601-10. PubMed ID: 8701455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of granulocyte colony-stimulating factor administration in healthy donors before bone marrow harvesting.
    MacHida U; Tojo A; Takahashi S; Iseki T; Ooi J; Nagayama H; Shirafuji N; Mori S; Wada Y; Ogami K; Yamada Y; Sakamaki H; Maekawa T; Tani K; Asano S
    Br J Haematol; 2000 Mar; 108(4):747-53. PubMed ID: 10792279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic recovery in patients who are treated with autologous stem cells transplantation taken from bone marrow after granulocyte-colony-stimulating factor stimulation.
    Gawronski K; Rzepecki P; Oborska S; Wasko-Grabowska A
    Transplant Proc; 2011 Oct; 43(8):3114-5. PubMed ID: 21996240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'In vivo' time course of plasma myeloperoxidase levels after granulocyte colony-stimulating factor-induced stem cell mobilization.
    Morabito F; Tomaino A; Cristani M; Martino M; Minciullo PL; Saija A; Gangemi S
    Transfus Med; 2005 Oct; 15(5):425-8. PubMed ID: 16202058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of short G-CSF administration on the numbers and clonogenic efficiency of hematopoietic progenitor cells in bone marrow and peripheral blood of normal donors.
    Zaucha JM; Knopińska-Posłuszny W; Bieniaszewska M; Myśliwski A; Hellmann A
    Ann Transplant; 2000; 5(4):20-6. PubMed ID: 11499355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rHuG-CSF increases the platelet-neutrophil complex formation and neutrophil adhesion molecule expression in volunteer granulocyte and stem cell apheresis donors.
    Karadogan C; Karadogan I; Bilgin AU; Undar L
    Ther Apher Dial; 2006 Apr; 10(2):180-6. PubMed ID: 16684221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of bone marrow signal changes on magnetic resonance tomography during high-dose chemotherapy and peripheral blood stem cell transplantation in patients with breast cancer.
    Altehoefer C; Laubenberger J; Lange W; Kraus A; Allmann KH; Uhrmeister P; Langer M
    Invest Radiol; 1997 Oct; 32(10):613-20. PubMed ID: 9342121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Granulocyte Colony-Stimulating Factor on Immune-Modulatory Cytokines in the Bone Marrow Microenvironment and Mesenchymal Stem Cells of Healthy Donors.
    Ok Bozkaya I; Azik F; Tavil B; Koksal Y; Ozguner M; Tunc B; Uckan Cetinkaya D
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1888-94. PubMed ID: 26265462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.